Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function
Clinical trial NCT02678000 · COMPLETED
Trial details
- NCT number
- NCT02678000
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-10
- Primary completion
- 2018-10-11
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.